The IPO Buzz: IPO Shock, Awe and Never Mind
The good, the bad and the ugly all surfaced in last week’s IPO market. None were expected.
Category Archives: The IPO Buzz
The IPO Buzz: IPO Candy and Clouds
Last week’s newly minted IPOs danced among the stars. Experts expect pretty much the same from this week’s calendar. It has 11 deals looking to raise over $2 billion. Among them are a couple of cloud-computer companies, four from the financial sector, and oh, yes, Candy Crush Saga is going public.
The IPO Buzz: Tech IPOs Take Off
Tech IPOs have arrived. Six of the 11 names on this week’s new-issues calendar are technology deals. And the sector’s aftermarket performance has been soaring.
The IPO Buzz: Tech IPOs on a Joyride
Fasten your seatbelts for a wild ride on the IPO highway. The technology sector is arriving. There is one deal on this week’s calendar plus three on next week’s; the filings continue to build, and their aftermarket performances are breathtaking.
The IPO Buzz: Tech IPOs Light Up the Sky
The year’s first tech IPO popped with an opening-day moonshot, 2013’s last tech IPO lit up the sky with an opening-day starburst – and this week’s calendar features a tech IPO called Coupons.com.
The IPO Buzz: IPO Jockeys and Litmus Tests
There are only two deals on this week’s IPO calendar. Each has a message. One borrows from the wisdom of the racetrack. The other is a litmus test for what could be a wave of technology IPOs.
The IPO Buzz: Tech IPO Trade Winds
Last week’s traffic clearly signaled a shift in the trade winds sweeping through the Valley of IPOs. The cannonball run for the biotech sector looks like it’s over, but another sector is opening – technology.
The IPO Buzz: The Ticking of the Bio-IPO Clock
Today’s “hot” IPO sector is starting to show signs of age. But if you listen to the wind, changes are in the works.
The IPO Buzz: The Running of the Biotechs
IPO players are ready to join the running of the biotechs through the canyons of Wall Street this week. Eleven of the 14 IPOs that are on the calendar are biotechs. And last week’s traffic was dominated by – yes – biotechs. Four of the eight IPOs that were priced were from this sector. A couple scored opening-day moonshots.
The IPO Buzz: Red-Hot Bio-IPOs
The days of the biotech and biopharma companies are coming to Wall Street. Three of the six IPOs on this week’s calendar are bio-IPOs and eight – yes, eight – of next week’s 10 IPOs are bio-IPOs. The emergence of this industrial sector should not be surprising. It has been sizzling.